Fielmann Group AG (XSWX:FIE) Research & Development: CHF0 Mil (TTM As of Mar. 2026)


XSWX:FIE Fielmann Group AG XSWX:FIE
85 GF Score
Price CHF40.45
GF Value CHF49.51
! 2 Warning Signs
View Full Analysis

What is Fielmann Group AG Research & Development?

Fielmann Group AG XSWX:FIE 85 Research & Development is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:FIE with a GF Score™ of 85/100 and a GF Value™ of CHF49.51. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fielmann Group AG's Research & Development for the three months ended in Mar. 2026 was CHF0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was CHF0 Mil.

Fielmann Group AG  (XSWX:FIE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fielmann Group AG Research & Development Related Terms

Fielmann Group AG Research & Development Historical Data

* Premium members only.

The historical data trend for Fielmann Group AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fielmann Group AG Research & Development Chart

Fielmann Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fielmann Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:FIE
85GF Score
Fielmann Group AG XSWX:FIE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fielmann Group AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0 Mil mean?
Fielmann Group AG (XSWX:FIE) has a Research & Development of CHF0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Fielmann Group AG and its competitors.
Is Fielmann Group AG's Research & Development too high?
Fielmann Group AG's current Research & Development is CHF0 Mil. Overall, Fielmann Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Research & Development compare to ISRG and BDX?
Fielmann Group AG's Research & Development of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fielmann Group AG and its competitors. Fielmann Group AG's current Research & Development is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Research & Development of CHF0 Mil. The stock's GF Value™ is CHF49.51, compared to a current price of CHF40.45 — trading 18.3% below its estimated fair value. The current Research & Development is CHF0 Mil. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Research & Development is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?

Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued. The current stock price of CHF40.45 is trading 18.3% below its estimated GF Value™ of CHF49.51.

Key valuation signals for XSWX:FIE:

  • Research & Development: CHF0 Mil
  • GF Value™: CHF49.51 vs. price of CHF40.45 (18.3% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fielmann Group AG Business Description

Address Fuhlsbuttler Strabe 399, Hamburg, DEU, 22309
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score

Get the complete analysis for XSWX:FIE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF40.45
Price
CHF49.51
GF Value